MedTrace Logo

Doxycycline in Therapy of Erythema Migrans

NCT01475708 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2016-03-24

No results posted yet for this study

Summary

The investigators will compare the outcome of three groups of erythema migrans patients treated with doxycycline: a group without any accompanying symptoms, with mild symptoms and with severe symptoms that require lumbar puncture.

Conditions

  • Lyme Borreliosis

Interventions

DRUG

Doxycycline

100 mg PO bid, 14 days

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Principal Investigators

  • Franc Strle, MD PhD · UMC Ljubljana

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-10-31
Completion
2014-11-30

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01475708 on ClinicalTrials.gov